• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.

作者信息

Stollings Joanna L, Koo Grace, Lindsell Christopher J, Dear Mary Lynn, McCoy Allison, Rice Todd W, Phillips Elizabeth J, Stone Cosby A

机构信息

Department of Pharmaceutical Services, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

出版信息

J Allergy Clin Immunol Pract. 2023 Feb;11(2):632-635. doi: 10.1016/j.jaip.2022.08.043. Epub 2022 Sep 11.

DOI:10.1016/j.jaip.2022.08.043
PMID:36100133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9464306/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/9464306/0c708addee2f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/9464306/0c708addee2f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e055/9464306/0c708addee2f/gr1_lrg.jpg

相似文献

1
Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.在重症监护病房对新冠肺炎患者进行风险分层管理以去除低风险青霉素过敏标签。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):632-635. doi: 10.1016/j.jaip.2022.08.043. Epub 2022 Sep 11.
2
Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU.重症监护病房中基于风险分层的管理以去除低风险青霉素过敏标签
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1572-1575. doi: 10.1164/rccm.202001-0089LE.
3
Inconsistencies in penicillin allergy labels in hospital and primary care after allergy investigation.过敏调查后医院和基层医疗中青霉素过敏标签的不一致性。
Clin Exp Allergy. 2023 Sep;53(9):969-973. doi: 10.1111/cea.14347. Epub 2023 May 29.
4
Patient-reported penicillin allergy and intensive care unit outcomes in sepsis.患者自述的青霉素过敏与脓毒症患者在重症监护病房的治疗结局
J Allergy Clin Immunol Pract. 2024 Feb;12(2):519-521. doi: 10.1016/j.jaip.2023.10.034. Epub 2023 Oct 28.
5
Penicillin skin testing in the evaluation and management of penicillin allergy.青霉素皮试在青霉素过敏评估和管理中的应用。
Ann Allergy Asthma Immunol. 2011 Jan;106(1):1-7. doi: 10.1016/j.anai.2010.05.010. Epub 2010 Jul 3.
6
Penicillin Allergy: Mechanisms, Diagnosis, and Management.青霉素过敏：机制、诊断与管理
Prim Care. 2023 Jun;50(2):221-235. doi: 10.1016/j.pop.2022.11.002. Epub 2023 Feb 26.
7
Primary care physicians present a gap of knowledge regarding the management of penicillin allergy.
Pediatr Allergy Immunol. 2022 Sep;33(9):e13857. doi: 10.1111/pai.13857.
8
Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial.口腔挑战与常规护理评估危重症住院患者低风险青霉素过敏（ORACLE）：一项安全性和可行性的初步随机对照试验。
Intensive Care Med. 2024 Jun;50(6):913-921. doi: 10.1007/s00134-024-07448-x. Epub 2024 May 13.
9
Inaccurate penicillin allergy labels: Consequences, solutions, and opportunities for rhinologists.不准确的青霉素过敏标签：对鼻科医生的后果、解决方案和机会。
Int Forum Allergy Rhinol. 2023 Jun;13(6):973-978. doi: 10.1002/alr.23173. Epub 2023 May 9.
10
Assessing Low-Risk Penicillin Allergies in Critical COVID-19, A Novel Perspective on an Emerging Antibiotic Allergy Opportunity.评估重症 COVID-19 患者的低风险青霉素过敏情况：新兴抗生素过敏机遇的新视角
J Allergy Clin Immunol Pract. 2023 Feb;11(2):636-637. doi: 10.1016/j.jaip.2022.11.048.

引用本文的文献

1
Clearance of penicillin allergies via direct oral provocation testing (DOPT): a systematic review.通过直接口服激发试验（DOPT）清除青霉素过敏：一项系统评价
Antimicrob Steward Healthc Epidemiol. 2025 Jul 31;5(1):e167. doi: 10.1017/ash.2025.10080. eCollection 2025.
2
Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-Analysis.剖析口服激发试验方案：一项利用系统评价和荟萃分析数据对低风险青霉素过敏脱敏反应、预测因素及实践进行的描述性流行病学研究
Hosp Pharm. 2025 May 8:00185787251337626. doi: 10.1177/00185787251337626.
3
A systematic review and meta-analysis of interventions to delabel low-risk penicillin allergies with consideration for sex and gender.
一项关于去除低风险青霉素过敏标签干预措施的系统评价和荟萃分析，并考虑了性别因素。
Br J Clin Pharmacol. 2025 Mar;91(3):684-697. doi: 10.1111/bcp.16366. Epub 2024 Dec 19.
4
Patient-related factors impact the implementation of inpatient antibiotic allergy delabeling.患者相关因素影响住院患者抗生素过敏标签去除的实施。
J Allergy Clin Immunol Glob. 2024 Aug 21;3(4):100326. doi: 10.1016/j.jacig.2024.100326. eCollection 2024 Nov.
5
A call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions.呼吁解决造血干细胞移植患者的青霉素过敏标签问题：如何避免仓促决策。
Transpl Infect Dis. 2024 Oct;26(5):e14350. doi: 10.1111/tid.14350. Epub 2024 Aug 5.
6
Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot safety and feasibility randomised controlled trial.口腔挑战与常规护理评估危重症住院患者低风险青霉素过敏（ORACLE）：一项安全性和可行性的初步随机对照试验。
Intensive Care Med. 2024 Jun;50(6):913-921. doi: 10.1007/s00134-024-07448-x. Epub 2024 May 13.
7
A multicentre observational study to investigate feasibility of a direct oral penicillin challenge in de-labelling 'low risk' patients with penicillin allergy by non-allergy healthcare professionals (SPACE study): Implications for healthcare systems.一项多中心观察性研究，旨在调查非过敏专业医护人员通过直接口服青霉素挑战来解除“低危”青霉素过敏患者标签（SPACE 研究）的可行性：对医疗保健系统的影响。
J Infect. 2024 Mar;88(3):106116. doi: 10.1016/j.jinf.2024.01.015. Epub 2024 Feb 6.
8
Penicillin allergy de-labelling by non-allergists: a comparison of testing protocols.非过敏症专科医生对青霉素过敏标签的去除：检测方案比较
JAC Antimicrob Resist. 2023 Dec 19;5(6):dlad134. doi: 10.1093/jacamr/dlad134. eCollection 2023 Dec.
9
Assessing Low-Risk Penicillin Allergies in Critical COVID-19, A Novel Perspective on an Emerging Antibiotic Allergy Opportunity.评估重症 COVID-19 患者的低风险青霉素过敏情况：新兴抗生素过敏机遇的新视角
J Allergy Clin Immunol Pract. 2023 Feb;11(2):636-637. doi: 10.1016/j.jaip.2022.11.048.
10
Differences in beta-lactam and penicillin allergy: Beyond the West and focusing on Asia-Pacific.β-内酰胺类与青霉素过敏的差异：超越西方，聚焦亚太地区。
Front Allergy. 2022 Nov 22;3:1059321. doi: 10.3389/falgy.2022.1059321. eCollection 2022.